Stem Cells http://www.stemcellsportal.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online February 21, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2007-0725v1
26/5/1211    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marquez-Curtis, L.
Right arrow Articles by Janowska-Wieczorek, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marquez-Curtis, L.
Right arrow Articles by Janowska-Wieczorek, A.
Submitted on August 30, 2007
Accepted on February 15, 2008

THE STEM CELL NICHE

Carboxypeptidase M Expressed by Human Bone Marrow Cells Cleaves the C-terminal Lysine of SDF-1{alpha}: Another Player in Hematopoietic Stem/Progenitor Cell Mobilization?

Leah Marquez-Curtis 1, Ali Jalili 2, Kathleen Deiteren 3, Neeta Shirvaikar 2, Anne Marie Lambeir 3, Anna Janowska-Wieczorek 2*

1 Research and Development, Canadian Blood Services, Edmonton, Alberta, Canada
2 Research and Development, Canadian Blood Services, Edmonton, Alberta, Canada; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
3 Laboratory of Medical Biochemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium

* To whom correspondence should be addressed. E-mail: anna.janowska{at}blood.ca.


   Abstract

Carboxypeptidase M (CPM) is a membrane-bound zinc-dependent protease that cleaves C-terminal basic residues such as arginine or lysine from peptides/proteins. We examined whether CPM is expressed by hematopoietic and stromal cells and could degrade stromal cell-derived factor (SDF)-1{alpha}, a potent chemoattractant for hematopoietic stem/progenitor cells (HSPC). We found that (i) CPM transcript is expressed by bone marrow (BM) and mobilized peripheral blood (mPB) CD34+ cells, myeloid, erythroid and megakaryocytic cell progenitors, mononuclear cells (MNC), polymorphonuclear cells (PMN) and stromal cells including mesenchymal stem cells; and that (ii) granulocyte-colony stimulating factor (G-CSF) significantly increases its expression at the gene and protein levels in MNC and PMN. Moreover, we found that recombinant CPM cleaves full-length SDF-1{alpha} (1-68) rapidly, removing the C-terminal lysine and yielding des-lys SDF-1{alpha} (1-67). We demonstrated that such CPM treatment of SDF-1{alpha} reduced the in vitro chemotaxis of HSPC, which, however, was preserved when the CPM was exposed to the carboxypeptidase inhibitor DL-2-mercaptomethyl-3-guanidino-ethylthiopropanoic acid. Thus we present evidence that CPM is expressed by cells occurring in the BM microenvironment and that the mobilizing agent G-CSF strongly upregulates it in MNC and PMN. We suggest that cleavage of the C-terminal lysine residue of SDF-1{alpha} by CPM leads to attenuated chemotactic responses and could facilitate G-CSF-induced mobilization of HSPC from BM to PB.

______________________________________________________________________________

A.J. and K.D. contributed equally to this manuscript.

Key Words. Carboxypeptidase M, stromal cell-derived factor-1, CXCR4, G-CSF, mobilization, bone marrow







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 2008 by AlphaMed Press.